ANVS
Annovis Bio Inc
NYSE: ANVS · HEALTHCARE · BIOTECHNOLOGY
$1.98
+7.34% today
Updated 2026-04-30
Market cap
$60.09M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.40
Dividend yield
—
52W range
$1 – $6
Volume
0.8M
Annovis Bio Inc (ANVS) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2009 | 2010 | 2011 | 2012 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $1.52M | $22.05M | $21.01M | $2.84M | $357963.00 | $50992.00 | $1.12M | $8.12M | $46.00M | $36.02M | $10.21M | $13.93M |
| Cash & equivalents | $31756.00 | $4.40M | $1.39M | $72316.00 | $347472.00 | $35312.00 | $1858.00 | $8.07M | $45.69M | $28.38M | $5.75M | $10.55M |
| Current assets | $121020.00 | $13.07M | $13.09M | $1.59M | $357963.00 | $50992.00 | $747512.00 | $8.12M | $46.00M | $36.02M | $10.21M | $13.93M |
| Total liabilities | $45491.00 | $5.55M | $7.09M | $174363.00 | $7.32M | $7.64M | $9.69M | $578380.00 | $1.51M | $7.70M | $17.96M | $4.62M |
| Current liabilities | $45491.00 | $5.55M | $7.09M | $174363.00 | $490220.00 | $567943.00 | $2.01M | $578380.00 | $1.51M | $7.70M | $4.28M | $3.88M |
| Long-term debt | — | — | — | — | — | — | $499807.00 | — | — | — | — | — |
| Shareholder equity | $1.48M | $16.49M | $13.93M | $2.66M | $-6.97M | $-7.59M | $-8.58M | $7.54M | $44.49M | $28.32M | $-7.75M | $9.31M |
| Retained earnings | $-739448.00 | $-1.93M | $-6.68M | $-15.00M | $-7.07M | $-7.79M | $-8.78M | $-14.24M | $-28.73M | $-54.05M | $-110.26M | $-134.85M |
| Accounts receivable | $2547.00 | $3.35M | $5.05M | $1.47M | — | — | $735075.00 | — | — | — | — | — |
| Inventory | $81490.00 | $4.49M | $5.25M | $22814.00 | — | — | $-745.64M | — | — | — | — | — |
| Goodwill | — | $6.27M | $4.20M | — | — | — | — | — | — | — | — | — |